Approval · Notice of Compliance 30955 · 2023
XENICAL: Notice of Compliance 30955
Issued June 8, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30955
- Date
- June 8, 2023
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the Product Monograph. Product Monograph reformatted to the Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XENICAL | Not yet assigned | — |
Medicinal ingredients
- ORLISTAT 120 MG per CAP